Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Skoda

Showing results (31-40 of 168) with videos related to

Pageof 17
Sort By:
Ceskoslovenska Psychiatrie|June 1, 1970
W.P.A.--R.M.P.A. symposium on psychiatric epidemiology. University of Aberdeen, July 23-25, 1969C Skoda, J Vána
Ceskoslovenska Psychiatrie|January 1, 1979
[The first admission rates for effective disorder in Prague, CSR, SSR and England (author's transl)]C Skoda, P Baudis
Blood|September 15, 1999
A single-base deletion in the thrombopoietin (TPO) gene causes familial essential thrombocythemia through a mechanism of more efficient translation of TPO mRNAN Ghilardi, R C Skoda
The Journal of Experimental Medicine|March 21, 2019
Dual roles of <i>EZH2</i> in acute myeloid leukemiaRadek C Skoda, Juerg Schwaller
Cancer Cell|February 15, 2011
HiJAKing the methylosome in myeloproliferative disordersRadek C Skoda, Jürg Schwaller
Molecular Endocrinology (Baltimore, Md.)|April 1, 1997
The leptin receptor activates janus kinase 2 and signals for proliferation in a factor-dependent cell lineN Ghilardi, R C Skoda
Blood Reviews|December 2, 2004
Molecular pathogenesis of Philadelphia chromosome negative myeloproliferative disordersRobert Kralovics, Radek C Skoda
Schweizerische Rundschau Fur Medizin Praxis = Revue Suisse De Medecine Praxis|January 9, 1990
[A case from practice (158). Type I diabetes in remission. Type II diabetes]C Skoda, G A Spinas
Biomedical Papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia|February 5, 2021
Mouse models of myeloproliferative neoplasms for pre-clinical testing of novel therapeutic agentsJan Stetka, Radek C Skoda
Blood|May 29, 2000
Translational pathophysiology: a novel molecular mechanism of human diseaseM Cazzola, R C Skoda
Pageof 17

Showing results (31-40 of 168) with videos related to

Sort By:
Pageof 17
Ceskoslovenska Psychiatrie|June 1, 1970
W.P.A.--R.M.P.A. symposium on psychiatric epidemiology. University of Aberdeen, July 23-25, 1969C Skoda, J Vána
Ceskoslovenska Psychiatrie|January 1, 1979
[The first admission rates for effective disorder in Prague, CSR, SSR and England (author's transl)]C Skoda, P Baudis
Blood|September 15, 1999
A single-base deletion in the thrombopoietin (TPO) gene causes familial essential thrombocythemia through a mechanism of more efficient translation of TPO mRNAN Ghilardi, R C Skoda
The Journal of Experimental Medicine|March 21, 2019
Dual roles of <i>EZH2</i> in acute myeloid leukemiaRadek C Skoda, Juerg Schwaller
Cancer Cell|February 15, 2011
HiJAKing the methylosome in myeloproliferative disordersRadek C Skoda, Jürg Schwaller
Molecular Endocrinology (Baltimore, Md.)|April 1, 1997
The leptin receptor activates janus kinase 2 and signals for proliferation in a factor-dependent cell lineN Ghilardi, R C Skoda
Blood Reviews|December 2, 2004
Molecular pathogenesis of Philadelphia chromosome negative myeloproliferative disordersRobert Kralovics, Radek C Skoda
Schweizerische Rundschau Fur Medizin Praxis = Revue Suisse De Medecine Praxis|January 9, 1990
[A case from practice (158). Type I diabetes in remission. Type II diabetes]C Skoda, G A Spinas
Biomedical Papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia|February 5, 2021
Mouse models of myeloproliferative neoplasms for pre-clinical testing of novel therapeutic agentsJan Stetka, Radek C Skoda
Blood|May 29, 2000
Translational pathophysiology: a novel molecular mechanism of human diseaseM Cazzola, R C Skoda
Pageof 17